Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2008, Vol. 28 Issue (2): 21-24    DOI:
    
Construction and expression of human sApo2L-Fc fusion protein in CHO cells
Download: HTML   PDF(425KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Abstract: Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL, Apo-2L) is a mediator of cell death that preferentially targets cancer cells. The C-terminal extracellular region of Apo-2L (amino acids 114-281) exhibits a homotrimeric subunit structure. Soluble Apo-2L(sApo-2L) induces extensive apoptosis in lymphoid as well as non-lymphoid tumor cell lines. But it is limited in its efficacy by the short circulating half-life and low stability. sApo2L-Fc is a fusion protein consisting of Apo-2L and a fragment(hinge, CH2, CH3 domains) of the Fc of the IgG1. The DNA was constructed in the pcDNA3.1(+) eukaryotic expression vector. Using DOTAP-mediated gene transfer technique, pcDNA3.1- sApo2L-Fc was transformed into Chinese hamster ovary(CHO) cells. The selective medium containing G418 was then employed to select the positive colony. After purified with protein A affinity chromatography, the product was detected with SDS-PAGE and Western blot. A protein band with molecular weight of 44KDa was found in the SDS-PAGE. Western blot displayed the recombinant product had strong immunological activity with mouse anti-human Fc monoclonal antibody. After purification, the biological activity of sApo2L-Fc was more than 1.0×105IU/mg.



Key wordssApo-2L      Fc-fusion protein      CHO cell      Eukaryotic expression systerm     
Received: 19 July 2007      Published: 25 February 2008
ZTFLH:  Q786  
Cite this article:

. Construction and expression of human sApo2L-Fc fusion protein in CHO cells. China Biotechnology, 2008, 28(2): 21-24.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2008/V28/I2/21

[1] Ying CHEN,Hai-peng XIAO,Xiao-yan ZHANG,Qing-wei GONG,Li MA,Wen-jia LI,Xiao-feng CHEN. Expression and Characterization of Recombinant GLP-1-IgG4-Fc Fusion Protein[J]. China Biotechnology, 2018, 38(7): 58-66.
[2] WEN Jia-ming, NIE Yan-feng, LIANG Han-zhang, HUANG Wen-xi, LEI Yun, XIE Qiu-ling, PEI Yun-lin, XIONG Sheng. MG-132 Improve the Production of TNFR-Fc Fusion Protein in CHO Cells[J]. China Biotechnology, 2015, 35(9): 1-6.
[3] YAN Li, WANG Kang, LI Rui-jian, BAI Yi, BAI Xian-hong, ZHOU Hai-ping. Manufaction of a New High-glycosylated Fusion Protein NESP-Fc[J]. China Biotechnology, 2015, 35(4): 80-85.
[4] DENG Chun-ping, TAO Jian-jun, HOU Yong-min, ZHONG Ling. Expression of hK1-L-Fc Fusion Protein in CHO Cells and Analysis of its Bioactivity[J]. China Biotechnology, 2011, 31(03): 23-28.
[5] SONG Xiao-Gong, XU Ting, LI Bing, FU Ling, HOU Li-Hua, CHEN Wei. Enhanced Production of Human Nerve Growth Factor by CHO Cells Through the Control of Culture Conditions[J]. China Biotechnology, 2010, 30(04): 13-19.
[6] . Serum-free aggregate perfusion culture of CHO cells: an ultrasonic and sedimentation column combined perfusion system[J]. China Biotechnology, 2008, 28(4): 53-58.
[7] . Localization of hepatitis B surface antigen within recombinant CHO cells in response to dimethyl sulfoxide[J]. China Biotechnology, 2008, 28(2): 16-20.
[8] . Culture of microencapsulated endostatin-CHO cells[J]. China Biotechnology, 2007, 27(9): 1-7.